◼ Archived
Health
Novel Injectable Drug Cuts Visceral Fat in Phase 2 Trial
A novel injectable drug called CBL-514 is drawing attention for reducing visceral fat and targeting fat cells without Ozempic or surgery.
Injectable
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
Injectable nanoparticles make blind retinas respond to light in preclinical study
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.